Sanofi-Aventis U.S. LLC has voluntarily recalled all lots of various Zantac (ranitidine) products, including Regular Strength 75 mg, Maximum Strength 150 mg, and Cool Mint variants. The recall was initiated because the product may contain N-nitrosodimethylamine (NDMA), an impurity classified as a probable human carcinogen. Consumers who have these products should contact their healthcare provider or pharmacist for guidance on alternative treatments and return the items to the place of purchase for a refund.
The product was found to contain NDMA, a substance that is suspected of causing cancer in humans based on laboratory tests. While NDMA is a common environmental contaminant found in water and foods, its presence in a medication at unexpected levels poses a potential long-term health risk.
Full refund upon return of product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.